Recent News

By Region: North America

Florida Man Charged in Toxin Sale Appears in New Jersey Court

(NBC6 South Florida) A Florida man who allegedly sold poison to an undercover agent and said it was capable of killing someone within two days made his first court appearance in New Jersey on Tuesday to face charges that could put him in prison for life. Jesse Korff appeared in U.S. District Court shackled and Read More »

February 12, 2014
| Filed under North America, Agents & Toxins, and Biocrimes
Share

Uganda: CDC Health Projects Improve Disease Detection and Control

(All Africa) The US Centres for Disease Control and Prevention (CDC) global health security (GHS) projects on early disease detection, response and prevention in Uganda and Vietnam have resulted in improvements in those areas. This was revealed in an article published in the Morbidity and Mortality Weekly Report released by CDC on January 30. For Read More »

February 12, 2014
| Filed under Africa, Asia/Pacific, North America, Agents & Toxins, Biosafety, Countermeasures, and International
Share

Sarepta’s bioterrorism drug found safe in humans

(Boston Business Journal) While most attention on Sarepta Therapeutics has concerned its drugs for Duchenne’s muscular dystrophy, today the Cambridge biotech reported data from an early-stage trial of its potential drug for the bio-terrorism infection known as the Marburg virus. Marburg is a deadly infection disease first recognized in 1967 and endemic to Africa. Its Read More »

February 12, 2014
| Filed under North America, Bioterrorism, Countermeasures, and Research
Share

EPA Study on Bioterrorism Decontamination Techniques

(Global Biodefense) The U.S. Environmental Protection Agency (EPA), along with federal partners, this week announced the results of a multi-year project called Bio-Response Operational Testing and Evaluation (BOTE) that tested and evaluated decontamination techniques for a biological incident.

February 12, 2014
| Filed under North America, Biosafety, Bioterrorism, and Research
Share

Newly found tactics in offense-defense struggle with hepatitis C virus

(EurekAlerts) The hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection. It also turns out that some people are genetically equipped with a strong countermeasure to the virus’ attempt to weaken the attack on it. The details of these findings suggest potential targets for treating HCV, Read More »